Product Description
Product Name: Afatinib CAS NO:439081-18-2
Synonyms:
Tovok;BIBW2992;
(S)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-;
(E/Z)-Afatinib;
Afatinib cis-trans isomer;
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-;
(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;
(2E)-N-(4-[(3-chloro-4-fluorophenyl)amino]-7-{[(3S)-tetrahydrofuran-3-yl]oxy}quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;
Chemical & Physical Properties
Appearance :Off-white solid.
Assay : ≥99.5%
Density | 1.380g/cm3 |
Boiling Point | 676.917ºC at 760 mmHg |
Melting Point | 100 - 102 °C |
Flash Point | 363.186ºC |
Refractive Index | 1.668 |
BIBW 2992 is an anilino-quinazoline that irreversibly inhibits EGFR and HER2 kinase activity.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.